Metraipolis › archive › dc_07201c39d16f

Multi-omics profiling identifies ADAM9 as a key efferocytosis driver in lung adenocarcinoma — Europe PMC PMID:42266684

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42266684
DOI
10.3389/fimmu.2026.1772167
License (as archived)
solo-consultazione
Archived
2026-11-01T06:19:24.457Z
SHA-256 of the archived text
33f1d125f5623b784b80d83bb594da927700748565e3cc3368b3a7d92fcf6552
Stable URL of this page
https://metraipolis.com/documento/dc_07201c39d16f

How to cite

Multi-omics profiling identifies ADAM9 as a key efferocytosis driver in lung adenocarcinoma — Europe PMC PMID:42266684 — Europe PMC (en), https://europepmc.org/article/MED/42266684 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07201c39d16f (Metraipolis archive dc_07201c39d16f, sha256 33f1d125f5623b784b80d83bb594da927700748565e3cc3368b3a7d92fcf6552)
BibTeX
@misc{dc07201c39d16f,
  title = {Multi-omics profiling identifies ADAM9 as a key efferocytosis driver in lung adenocarcinoma — Europe PMC PMID:42266684},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42266684},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07201c39d16f; sha256 33f1d125f5623b784b80d83bb594da927700748565e3cc3368b3a7d92fcf6552},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42266684. Agents can read the archived copy with the MCP tool read_document.